Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 350,065 | 173,381 | 372,260 | 338,341 | 297,304 |
| Marketable Securities | 1,704,520 | 1,745,732 | 2,305,176 | 1,901,830 | 1,992,676 |
| Receivables | 58,845 | 73,684 | 66,059 | 24,608 | 52,580 |
| Inventories | 50,833 | 5,557 | 10,048 | 10,470 | 8,481 |
| Other current assets | 327,011 | 938,591 | 237,092 | 243,744 | 226,109 |
| TOTAL | $2,491,274 | $2,936,945 | $2,990,635 | $2,518,993 | $2,577,150 |
| Non-Current Assets | |||||
| PPE Net | 155,131 | 142,401 | 123,048 | 106,117 | 111,951 |
| Other Non-Current Assets | 348,096 | 370,623 | 410,153 | 407,981 | 296,032 |
| TOTAL | $503,227 | $513,024 | $533,201 | $514,098 | $407,983 |
| Total Assets | $2,994,501 | $3,449,969 | $3,523,836 | $3,033,091 | $2,985,133 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 431,948 | N/A | N/A |
| Accounts payable and accrued liabilities | 47,704 | 26,030 | 28,082 | 14,326 | 22,800 |
| Accrued Expenses | 166,071 | 162,598 | 222,325 | 156,329 | 145,521 |
| Other current liabilities | 25,149 | 23,390 | 22,738 | 24,803 | 22,806 |
| TOTAL | $315,638 | $716,591 | $781,567 | $903,456 | $897,236 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 59,074 |
| Deferred Revenues | 73,837 | 69,199 | 73,761 | 76,986 | 75,910 |
| Other Non-Current Liabilities | 2,176,096 | 2,166,219 | 2,161,179 | 1,403,762 | 1,272,004 |
| TOTAL | $2,239,126 | $2,241,964 | $2,253,180 | $1,511,668 | $1,456,173 |
| Total Liabilities | $2,554,764 | $2,958,555 | $3,034,747 | $2,415,124 | $2,353,409 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 166,184 | 165,263 | 165,192 | 161,974 | 159,391 |
| Common Shares | 166 | 166 | 163 | 161 | 159 |
| Retained earnings | -2,838,369 | -2,723,723 | -2,631,195 | -2,401,801 | -2,273,195 |
| Other shareholders' equity | -33,897 | -31,023 | -25,281 | -25,978 | -27,987 |
| TOTAL | $439,737 | $491,414 | $489,089 | $617,967 | $631,724 |
| Total Liabilities And Equity | $2,994,501 | $3,449,969 | $3,523,836 | $3,033,091 | $2,985,133 |